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4.1 Introduction 
Polyhydroxyalkanoates (PHA) are biopolyesters with good biodegradability and 
biocompatibility with broad application potential. The composition of monomeric building 
blocks, microstructures, and supra-macromolecular architecture determine the chemo-
mechanical properties of PHA, and thus their suitability for defined technological 
applications [1, 2]. PHA were first discovered in the cytosols of certain microorganisms as 
high molar mass polymers stored in the form of granules [1]. These high molar mass PHA 
have more than 1 000 3-hydroxyacid residue units (approximately 50–5 000 kDa) and are 
generally referred to as storage PHA (sPHA) [3]. In certain prokaryotic bacteria, PHA are 
synthesized intracellularly in the form of inclusion bodies in their cytosols with their main 
function being for carbon and energy [4]. Much later, a low molar mass form of PHA referred 
to as PHA oligomers was discovered and reported by Reusch and Sadoff [5]. Consequently, 
PHA have now been classified into high molar mass PHA and low molar mass PHA (PHA 
oligomers), based on their molar mass. 
PHA oligomers (oligo-PHA) are low molar mass PHA consisting of a small number of 3-
hydroxyacids repeat units, usually three or more 3-hydroxyacids residue units, but not more 
than 200 residue units [6]. They are built from the same monomer units as sPHA, but possess 
a much shorter chain. While sPHA are primarily formed in many prokaryotes (Eubacteria and 
Archaea), PHA oligomers are components of all prokaryotes and eukaryotes and are thus 
thought to be present in all living organisms [3].  
Over the last few years, storage PHA have been extensively studied and considered a more 
attractive biomaterial in research with high future impact due to their desirable properties and 
extensive applications. Nevertheless, the insufficient yields and poor mechanical properties of 
PHA limit its widespread commercialization. This is partly due to their hydrophobic nature (a 
long-chain fatty hydroxyl acid molecule) that results in fewer functional groups [7]. As a 
result, their applications in other advanced areas of importance are limited. Thus, to expand 
their widespread commercialization and improve their potential applications, PHA would 
need to have appropriate hydrolytic stability and enhanced chemical functionalities. This 
would improve their mechanical properties, amphiphilic character, and surface structure to 
meet the requirements of their tailored application [7, 8]. To achieve this, PHA oligomers 
containing reactive functional end groups with controlled -molar mass can be used as building 
blocks of new block biopolymers with enhanced properties [9]. Furthermore, the high 
biocompability, bioactive function, and block copolymerisation of PHA oligomers with other 
polymers have been discovered to exhibit desirable properties for valued-added biomaterial 
applications, especially in medicine for therapeutic use, cosmetology, and agrichemistry [2, 
10, 11]. Moreover, several researchers have also identified and confirmed the various range 
of PHA oligomers with high potential for being a good source of reactive oligoesters [12, 13, 
14, 15, 16]. Thus, with these developments, it is expected that there would be an amplified 
interest in the functionalization of PHA biomaterials for other novel applications.  
The physical properties of PHA oligomers are chiefly dependent on the length of the chain 
[17]. Aside from being biodegradable, PHA oligomers also exhibit excellent biocompatibility 
as confirmed by their lack of toxicity. This is well demonstrated by the natural presence of 
relatively large amounts of low-molar mass poly(3-hydroxybutyrate) (PHB) and other related 
oligomers in the bloodstream of humans [18]. In addition, PHA oligomers are components of 
all living organisms including eukaryotic cells and mammals where they are widely 
distributed in various intracellular fluids and fractions of these cells. In most cases, a short-
chain form of low molecular mass (oligo-PHA) PHA  is complexed to other cellular 
macromolecules such as proteins and inorganic polyphosphates and thus referred to as 
complexed PHA (cPHA).  
4.2 Oligomers Derived from Natural Storage 
4.2.1 Oligo-PHB 
Oligo-PHB was first discovered by [5] in the cytoplasmic membrane of Azotobacter 
vinelandii and Bacillus subtilis, comprising about 100–200 monomeric units. Oligo-PHB is 
known to often form complexes with calcium ions and polyphosphate (polyP) and is 
suggested to be responsible for the uptake of DNA during transformation [3]. Oligo-PHB is 
also part of low-density lipoproteins in human plasma and thus is suggested to be involved in 
arteriosclerosis [19]. 
4.2.2 Complexed PHB 
cPHB was first discovered in Escherichia coli, but it has ever since then been found to be a 
ubiquitous constituent of both prokaryotic and eukaryotic cells. They usually consist of a low 
number of 3HB units (<~30) [3, 20] and are widely distributed in numerous cell fractions 
mostly in complex with other bio-macromolecules including inorganic polyPs and proteins 
[21]. They are usually water-soluble and chloroform-insoluble as long as the protein 
molecule to which it is attached to is water-soluble [3]. The majority of cPHB is complexed 
covalently with proteins, while a small fraction of them are non-covalently complexed with 
calcium polyP [22]. There is evidence from several reporters that these polyP complexes play 
a major role in the acquisition of competence in Escherichia coli, where they form ion 
channels in their plasma membranes [23, 24]. In addition, the covalent modification of 
proteins by cPHB, referred to as PHBylation, could have an important effect on the 
physiological properties of proteins. A significant amount of cPHB in E. coli is dependent on 
the presence of a novel type of PHB synthase called YdcS, different from sPHB synthase 
[25].  
4.2.3 Synthesis of Natural PHA Oligomers 
Oligomeric PHA could be synthesized either through intracellular degradation of PHA 
yielding natural oligomers, extracellular degradation or chemical modifications to yield 
synthetic oligomers. These pathways have been identified and confirmed by several 
researchers [26, 27, 28, 29]. The extracellular degradation and chemical modifications for 
oligomer synthesis have been reported by many studies [9, 30, 31, 32], but only a few studies 
have been published on the intracellular degradation of PHA [33, 34]. 
4.2.4 Intracellular Degradation of Storage PHA 
Intracellular degradation is the natural means by which PHA oligomers are being 
synthesized; it is, however, the less common route by which oligomers are synthesized, as 
gathered from the literature. This is because of the minute quantity of oligomeric PHA in 
cells, and thus the cellular mechanism behind the intracellular synthesis of PHA oligomers  is 
yet to be fully understood.  
So far, PHB has been extensively used to study the intracellular metabolism of PHA. 
Intracellular sPHB when accumulated with some intact surface layer and some PHB binding 
proteins in bacteria cells are referred to as native PHB (nPHB) or amorphous PHB (aPHB) 
[35]. If, however, these PHB-producing cells die (e.g.  after cell lysis or solvent extraction) 
with or without a damaged surface layer, they are released into the environment, denature, 
and turn out to be more or less crystalline (semicrystalline/paracrystalline state) [36]. 
Although the extracellular degradation of denatured crystalline, PHB (dPHB), has been 
amplified in numerous bacteria, only a little is known about the intracellular degradation of 
native PHB [36]. 
Based on reported in vivo studies, sPHBs are usually degraded intracellularly by PHB 
depolymerase (PhaZ1) to obtain natural PHA oligomers [34]. PhaZ1 has been found to occur 
only as a form bound to PHA granules in cells, with various 3-hydroxybutyrate (3HB) 
oligomers being its major hydrolytic products from the enzymatic degradation of amorphous 
PHB [35]. This in vivo degradation process as described for Ralstonia eutropha (today: 
Cupriavidus necator) starts in the chains of amorphous PHB molecules. In this process, 
several links are created in the chain by intracellular PHB depolymerase (iPHB-PhaZ1) 
bound to exclusively inclusion bodies [33, 37]. Consequently, medium-sized 3HB-oligomers 
(that still bind to the granules) are produced mostly due to their hydrophobicity. In addition to 
this, some loosened 3HB ends of PHB chains protruding from the granules are produced, as 
well as small amounts of short-chain 3HB-oligomers (3–5 units) which diffuse from the 
granules [33, 34]. However, as reported by several researchers, this is only applicable to 
native or amorphous PHB granules but not crystalline PHB granules [27, 38].  
Asides R. eutropha, there have been other reports on the intracellular degradation of sPHB in 
other bacteria such as Escherichia coli [35, 39, 40]. In most of these reported studies, PhaZ1 
of Ralstonai eurtopha H16 was cloned and just a few novel intracellular PhaZ genes were 
identified and characterized [27, 40, 41]. In a report by Saegusa and his colleagues [40], an 
intracellular poly[D(-3)-3-hydroxybutyrate] depolymerase gene (PhaZ) was cloned from 
R. eutropha and expressed in E. coli. The crude extract of E. coli containing PhaZ gene 
digested amorphous PHB granules and released majorly oligomeric D(-)-3-hydroxybutyrate 
with the addition of some monomers [40]. Furthermore, it was reported in recent studies that 
an increase in PhaZ activity during culturing of A. vinelandii led to a decrease in the average 
molecular weight of sPHB and an increase in the fraction of low molecular weight PHB [27, 
38, 42]. Besides these studies, no other study to the best of our knowledge has fully 
elucidated the metabolism behind the intracellular accumulation of PHA oligomers.  
4.2.5 Extracellular Degradation of Storage PHA 
Storage PHA that were synthesized by humans or released from PHA-accumulating 
microorganisms can be easily cleaved to by extracellular PHB depolymerases and many 
researchers have described numerous examples of extracellular PHB depolymerases over the 
last few decades [43, 44, 45, 46]. A good number of microbes, particularly bacteria and fungi 
in soil, sludge, and seawater have been reported to excrete extracellular PHA-degrading 
enzymes able to hydrolyze sPHA into water-soluble oligomers [29]. Subsequently, these 
organisms make use of the resulting products as nutrients within their cells. In one of these 
studies carried out by Sugiyama et al. [31], PHB depolymerases (PHBDPs) were purified 
from two different bacteria (Rasltonia pickettii T1 and Acidovorax sp. SA1) to investigate 
their degradation products, kinetic properties, and substrate specificity. It was discovered that 
for Ralstonia pickettii T1, an extracellular PHB depolymerases enzyme degrades extracellular 
PHB to numerous sized 3HB-oligomers, and for Acidovorax sp. SA1, an extracellular 
PHBDP hydrolyzes extracellular PHB to small 3HB-oligomers (dimer and trimer) [31]. In 
another study by Gebauer and Jendrossek [36], protease-treated PHA granules were degraded 
with extracellular PHA depolymerases isolated from P. lemoignei to obtain 3HB and 3HV 
oligomers. In addition, Utsunomia and his colleagues [30] also recently reported on the 
production of D-lactate-3HB oligomers (D-LAOs) by engineered Escherichia coli expressing 
a D-specific lactate polymerizing enzyme. The extracted oligomers in this study contained 
45 mol-% LA and 55 mol-% 3HB, suggesting that the obtained D-LAOs-DEG are random 
copolymers of LA and 3HB. The secreted D-LAOs also possessed two hydroxyl end group 
that can be used as building blocks for the production of numerous LA-based polymers 
including LA-based poly(ester-urethane) (PEU) [30]. 
4.2.6 Extraction of PHA Oligomers 
The detailed extraction of PHA oligomers from cells have been previously described by 
Reusch and Sadoff [47], which has also been modified by Seebach et al. and Suzuki et al. 
[48, 49]. 
Due to the low concentrations of cPHB in certain solvents comprising of either lipids only, or 
lipids with proteins, its physical properties are usually modified by these solvents. Thus, the 
solubility of cPHB is majorly dependent on the properties of its complexant, where cPHB 
may be found in the residue part of its complexant, in any of the wash solutions or in the 
aqueous hypochlorite supernatant [19]. Even when cPHB is isolated from samples with 
chloroalkanes, cPHB would most often fail to dissolve in boiling chloroform. Consequently, 
designing a general procedure for the isolation of pure cPHA has become impossible. Unlike 
in bacteria, where the isolation of PHB is mostly based on the relative stability of the polymer 
to alkaline hypochlorite, the isolation of cPHB using the same protocol is highly 
unpredictable [19, 50]. Thus, as suggested by Reusch [19], it is generally advisable to 
quantify cPHB before attempting to separate or isolate it.  
Reusch and Sadoff [47] first reported the isolation of cPHB from competent E. coli, where 
total PHB was extracted with cold CHCl3 to yield 9.6 µµg/g (wt/wt) wet mass of cPHB. 
Since then, only three pure cPHA have been successfully isolated. Seebach et al. [48] was 
able to extract cPHB from competent E. coli cells using an enhanced isolation procedure 
different from that used by Reusch and Sadoff [47]. Here, the pelleted cells were freeze-dried 
and the residue was extracted with dry CHCl3, saturated with cold (4°C) SDS. The remaining 
insoluble material was boiled for a long period in CHCl3. The extracts (both hot and cold) 
obtained afterward were purified by a Bio-Rad S-X3 bead treatment and further analyzed in a 
high-field NMR spectrometer. Both extracts showed signals of P(3-HB) with the hot extract 
containing significantly higher amounts. The hot extract was further purified by its 
continuous injection into a GPC system. Through this, chain lengths of cPHB were roughly 
assigned [48]. Seebach et al. [48] researched further to isolate cPHB component from 
spinach, beef-heart, human aortae, and mitochondria to obtain H-NMR detectable amounts. 
Through this study, it was established that cPHB extracted from E. coli and spinach leaves is 
composed of (R)-3-hydroxybutanoic acid moieties [48]. 
Further isolation of eukaryotic cPHA in its pure state from sugar beet (Beta vulgaris L.) has 
been described [49]. In this study two different methods were used to yield 500 µg (80 g beet 
powder) and 600 µg (100 g beet powder) of pure cPHA respectively (see Figure 4.1). 
The highest cPHA yield was observed using method 2. This was probably due to the addition 
of a partition procedure where the methanol precipitate was partitioned between chloroform 
and water (2:1) and this must have led to further reduction of impurities. 
It is important to note that for the isolation of low concentrations of cPHB from these 
samples, large amounts of samples were required. 
4.2.7 PHA Oligomers in Eukaryotes 
It is well known that sPHB is a ubiquitous biopolymer confined to certain prokaryotic 
bacteria. Low molecular weight PHB found complexed to other macromolecules (cPHB) has 
also been shown to be widely distributed in representative organisms of nearly all biological 
cells and phyla [51]. While it’s been reported that PHA oligomers are present in all living 
compartments of prokaryotic cells, it has, however, only been extensively examined in the 
Prokaryotic cell, Escherichia coli. Wild type E. coli is itself not capable of producing sPHA 
under normal growth conditions, but it has been found capable of producing small amounts of 
low molecular weight PHB complexed to cell membranes within its plasma membranes and 
not within its cytosols [47].  
Reusch [5] was the first to isolate this complex form of PHB from the cell membrane of 
competent E. coli while examining transitions in lipid phase membranes of Azotobacter 
vinelandii and Bacillus subtilis cells during the development of genetic competence. The 
increase in transformability was followed by the occurrence of a sharp and irreversible 
fluorescence peak corresponding to an increase in the concentration of PHB in the plasma 
membranes of E. coli. Naturally, PHB is not known to form intramolecular bonds and thus 
not capable of forming the quasi-crystalline structure on its own as indicated by the sharp 
fluorescence peak. As a result, the PHB was thought to be complexed and its complexant was 
assumed to be water-soluble due to a significant decrease in peak intensity when the cells 
were washed, especially with chelating buffers [5, 23]. PHB extracted from E. coli contained 
the anionic polymer PPi and Ca
2+ 
which were surmised to be complexants of PHB since these 
hydrophilic moieties are greatly insoluble in chloroform [51]. Furthermore, it was discovered 
in Reusch’s study [51], that this oligomer is located in the inner membrane of E. coli, where it 
occurs together with the calcium salt of inorganic polyP. The structure, composition, and 
distribution of the cPHB suggest that it may play a role in the regulation of intracellular 
calcium and in calcium signaling, as well as permitting calcium, DNA, or phosphate transport 
across its inner membrane [52]. Since then, E. coli has become the most preferred organism 
for cPHB studies. This is because it does not form inclusion bodies with sPHB that would 
otherwise have been difficult to separate from low  molar mass PHB. 
Huang and Reusch [20] further studied the presence of PHB in E. coli and discovered that the 
PHB in this cell is found all through the cells complexed to CaPolyPi and primarily 
associated with proteins. Furthermore, it was detected in this study that the properties of the 
protein-associated PHB were different from those of cellular inclusion sPHB. More than 80% 
of the PHB detected in E. coli were found in the cytoplasm, with the greatest concentration 
being observed in the ribosomal fraction [20, 53]. 
In another study by Tsuge et al. [54], low molar mass PHA was synthesized by R. eutropha 
engineered with recombinant plasmid pBBREE32d13 carrying PHA synthase of Aeromonas 
caviae. Marine Bacillus subtilis and Streptomyces lividans were also detected to produce 
oligo-PHB in associations with calcium ions and polyP [55].  
Since the regulation of calcium transport is being viewed as an important physiological 
function in bacteria, and PolyPi synthesis is also known to be widely distributed in eukaryotic 
systems, it was therefore important to investigate if cPHB also exists in eukaryotic 
membranes. To this end, there have been quite a few studies (49, 50, 52] on detecting the 
presence of cPHB in eukaryotic cells to which a number of eukaryotic cells have been 
investigated to synthesize and accumulate cPHB. These cells include yeast (Saccharomyces 
cerevisiae), sugar beet (Beta vulgaris L.), peanut, cat muscles, sheep (intestine), and spinach, 
further showing that oligomeric PHB has excellent biocompatibility in animals [22, 55, 56]. 
In these studies, the PHBs form complexes with polyphosphate, various lipids, or proteins 
and play a role in membrane transport, thus making its solubility performance unpredictable 
[48, 52, 57]. 
A survey carried out on plant and animal tissues by Reusch [52] showed that PHB is indeed 
synthesized by a wide variety of eukaryotic cells, further illustrating that PHB is nearly 
ubiquitous in all cells. The long-chain-length PHB with high dispersity that forms inclusion 
bodies in some bacteria was not found in these studied eukaryotic cells. Meanwhile, it was 
short-chain-length PHB associated with CapolyPi that was omnipresent in these cells. Just 
like in E.coli and other reported bacteria known to accumulate cPHB, cPHB was also found 
to be in membrane fractions of these eukaryotes, as indicated by the intracellular distribution 
of this complex in bovine liver [52], although the complex formed was primarily in the 
mitochondria and microsomes. The eukaryotic polyPi chain length was a little greater (170–
220) than that of bacterial PolyPi (130–170), although the eukaryotic cPHB had the same 
broad range of chain lengths (120–200 subunits) as those in bacterial membranes. As 
suggested by the ubiquitous nature of the complex, the structure of PHB-Ca-polyPi has an 
important physiological function. Furthermore, the intracellular distribution of the complex, 





, giving it the function of regulating intracellular Ca
2+
 and transmitting Ca
2+
 
signals [52].  
Previous work by Reusch [19] also showed that cPHB is present in minute quantities in 
human blood plasma (predominantly associated with low-density lipoproteins (LDL), human 
aorta, bovine heart, liver mitochondria, and bovine serum albumin [19, 48, 58]. Seebach et al. 
[48] also reported their study on the isolation of cPHB from several eukaryotic organisms 
including yeast, spinach leaves, celery leaves, celery stalk, chicken liver, beef liver, lamb 
heart, beef heart, and beef brain. 
To obtain more information on eukaryotic cPHA-biosynthesis mechanisms, Suzuki et al. [49] 
isolated a cPHA-component obtained from a complex with Ca-polyP from sugar beet (Beta 
vulgaris L.) and further determined its structure. This complex was discovered to be a 
homopolymer comprised of 3-hydroxybuyrate. Using MALDI MS, the number average  
molar mass and dispersity index of the isolated cPHA were determined to be Mn = 9 100 Da 
and Đ = 1.01 respectively, indicating that beet cPHA has a somewhat lower molar mass than 
the already known cPHA of Escherichia coli. Beet cPHB had a shorter chain PHB of n = 106 
with a much lower 3HV content than cPHA from E. coli. The structural analysis of the 
obtained cPHA in this study also revealed that 100 mol-% of the carboxyl end is free, about 
30 mol-% of the hydroxyl end is also free with about 70 mol-% of this end being masked, and 
the hydroxyl end group is also masked by at a minimum six identified short-chain alkanedioic 
and alkanoic acids [49]. These findings confirmed the organism-dependent structural 
diversity of cPHA (see also Figure 4.2). 
Suzuki et al. [21] also reported his findings from the isolation of cPHA from commercial 
baker’s yeast. In his study, 2.6 mg of pure cPHA (referred to as yeast cPHA-1) was isolated 
from 850 g dry weight of the yeast cells, making it the second cPHA being purified from 
eukaryotic organisms. The cPHA-1 obtained was further characterized using 
1
H-NMR which 
revealed four comonomers; 3-HV, 4-hydroxybutyrate (4-HB), 3-hydroxypropanoate (3-HP), 
and crotonate (CA). The presence of 3-HB, 3-HV, and very small units of CA was also 
confirmed by further GC-MS of cPHA-1 ethanolyzates. The amount of each comonomer in 
cPHA-1 was determined to be 1.03 mol-% of 3HV, 0.06 mol-% of 4-HB, 0.07 mol-% of 3-
HP, and 0.02 mol-% of CA. Notably, as observed in this study, yeast cPHA-1 had an almost 
identical monomer content to beet cPHA (0.1 mol-% 4-HB, 0.01 mol-% CA) but had a 
ca. 10-fold greater 3HV content than beet cPHA [21]. The Mn of cPHA-1 was observed to be 
57.4, which is much shorter than the chain length observed for beet cPHA. Significant signals 
indicating free-end 3-hydroxyl and carboxyl groups of cPHA-1 were also identified by the 
31
P NMR spectrum [21]. The content of these groups corresponded to 17.5% of the molecules 
for the hydroxyl groups and 3.6% of the molecules for the carboxyl groups. These values also 
suggested the presence of cyclic molecules. It was also discovered in this study that changing 
the culture medium could directly influence the molecular weight and not the polydispersity 
of cPHA from baker’s yeast.  
4.2.8 PHA Oligomers for the Structural Studies of Their Precursors by Mass Spectrometry 
The microstructure of high-molecular-weight bacterial PHA has been originally determined 
by 
13
C NMR based on diad and triad analysis. However, the significant information on PHA 
copolymers microstructure was provided by mass spectrometry. For this purpose, the 
theoretical mass spectra of PHA copolymers containing various compositions of repeat units 
were generated, and compared with those experimentally acquired with the aid of such “soft” 
MS ionization techniques as matrix-assisted laser desorption-ionization (MALDI), fast atom 
bombardment (FAB), desorption-chemical ionization (DCI), and electrospray-ionization 
mass spectrometry (ESI-MS) [59]. Moreover, the electrospray ionization multistage mass 
spectrometry (ESI-MS
n
) has been successfully applied for verification of PHA 
microstructure. By means of these methodologies, the random comonomer arrangements 
have been confirmed in poly(3-hydroxybutyrate-co-3-hydroxyvalerate), (PHBV), poly(3-
hydroxybutyrate-co-3-hydroxyhexanoate), (PHBH), copolymers, and recently for PHA with 
more than two different repeat units [60]. 
The ESI-MS/MS structural studies of bacterial PHA copolymers were based on the analysis 
of their oligomers obtained either by alkaline hydrolysis or controlled moderate-temperature 
degradation induced by carboxylate moieties. Using both of these approaches, oligomers 
containing carboxylic and olefinic end groups and the same composition and sequence 




C NMR, and 
ESI-MS/MS analysis [61]. 
4.2.9 Functionalization of PHA Oligomers Contained Unsaturated  End Groups 
PHA can be chemically modified to produce oligomers with the introduction of functional 
groups depending on the tailored functionality. So far, there have been several publications 
related to the various chemical modifications that can be employed for the production of 
synthetic oligomers [7, 26, 28]. 
4.2.10 Thermal Degradation  
This is the most widely employed degradation process used for the production of synthetic 
PHA oligomers. It is the degradation of polymer chains due to overheating, where at high 
temperatures, this process results in volatile monomers, dimers, and trimers [7]. At 
moderately low temperatures (170–200°C), the degradation of PHA results in the production 
of a well-defined oligomer (usually 500–10 000g/mol macromolecule) with an unsaturated 
group (predominantly a trans-alkenyl end group) and a carboxylic group. In Yu’s [62] patent, 
a controlled thermal degradation method was described to produce desired and well defined 
low  molar mass PHA with functional end groups. In this study, a chemically stable substance 
(e.g., diethylene glycol, poly(ethylene glycol) or tetraethylene glycol) with a high boiling 
point of about 250°C was added to the reaction process to serve as a solvent or diluter during 
the thermal degradation process of high  molar mass PHA. With this method, the window to 
obtain PHA oligomers with controlled  molar mass is large, so that the degradation process 
occurs in a better controlled manner, with improved heat transfer and more efficient stirring. 
Due to the large reaction period, a desirable molar mass can be achieved [62]. 
4.2.11 Controlled Moderate-Temperature Degradation 
Moderate-temperature degradation of poly(3-hydroxyalkanoate)s (3-PHA) can be induced by 
carboxylate groups according to E1cB mechanism (see Figure 4.3). In the case of 3-PHB with 






 counterions, the 
degradation induced by intermolecular α-deprotonation by carboxylate was suggested. It was 
assumed that this process is the main 3-PHA decomposition pathway at moderate 
temperatures. Oligomers containing carboxylic and unsaturated end groups were formed in 
this way [63]. 
Moreover, the degradation of 3-PHA with selected salts of organic and mineral acids was 
investigated. The significant decrease in 3-PHA thermal stability in the presence of salts of 
weak Bronsted-Lowry acids was observed due to an anionic degradation reaction proceeding 
via an E1cB mechanism. Furthermore, continuous poly(3-hydroxybutyrate) controlled 
degradation was developed by a moderate-temperature process using carbonic acid salts as 
“initiators” of moderate-temperature degradation. Foamed 3-PHA oligomeric 
macromonomers, were obtained by a reactive extrusion process [64]  
Furthermore, bacterial (P(3HB4HB)) degradation under mild reaction conditions induced by 
carboxylate salts leads to the thermal degradation of poly(3-hydroxybutyrate-co-4-
hydroxybutyrate) and allows the obtaining of uniform linear oligomers. Moderate reaction 
temperature conditions and the presence of carboxylate salt allow for avoiding of the 
degradation process through a back-biting reaction which occurs even when a small amount 
of 4HB repeating units is present [65]. 
4.2.12 Thermooxidative Degradation of PHB  
The thermal treatment of PHB in an oxygen/ozone mixture resulted in an increased rate of 
polymer backbone scission. The non-volatile degradation products contained macromolecules 
with several types of terminal groups, but also a part of the 3-hydroxybutyrate repeating units 
was transformed into 3-malic acid units. NMR and multistage MS characterization revealed 
the random distribution of 3-malic acid units in the oligomeric products as well as the content 
of the malic acid units being dependent on oxidation conditions [66].  
4.2.13 Microwave-Assisted Degradation and UV Irradiation  
Recently, microwave-assisted degradation of PHA has been employed as an inexpensive 
degradation route to PHA oligomers, since this method generates an efficient internal heating 
system by direct coupling of microwave energy with molecules [67, 68]. Here, sPHA samples 
are degraded in a microwave synthesis reactor operated at a desired power and temperature 
levels [9]. Ramier et al. [9] used this approach at 200°C–220°C to obtain high yields of 
oligomers (Mn ≤1 000 g/mol) characterized by a carboxyl group at one chain end and 
terminal crotonic ones on the other side. The obtained oligomeric PHA was also 
characterized by fluctuating molar masses in the shortest of times possible, about a 100 times 
faster rate than those obtained with conventional thermal degradation. This study further 
established that two microwave-assisted procedures could be successfully used: the first is 
irradiation with a constant temperature to obtain PHA oligomers with high yields and molar 
masses lower than 1 000 g/mol and the second is irradiation under constant power to afford 
oligoesters with higher molar masses [9]. Shangguan et al. [69] made use of UV irradiation to 
obtain oligomers with reactive radical groups after the quick controlled degradation of 
poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) [69, 70] 
4.2.14 Acid/Base Catalyzed Hydrolysis/Methanolysis of PHA 
In this method, PHA are subjected to hydrolysis in either acid or base, leading to a slow and 
well-controlled depolymerization of the aliphatic polyester chains. Timbart et al. [16] have 
reported the synthesis of well-defined mcl-PHA oligomers (Poly(3-hydroxyoctanoate) 
oligomers – PHO) from natural mcl-PHA using a basic hydrolysis, acid-catalyzed reaction 
with para-toluenesulfonoic acid monohydrate (APTS) and methanolysis catalyzed by H2SO4. 
The 
1
HNMR spectrum showed that the PHO oligomers produced by basic degradation at 
pH = 14 contained an unsaturated end group. However, more efficient production of PHO 
oligomers was observed with acid-catalyzed reaction and methanolysis. A MALDI-TOF 
spectra of PHO oligomers obtained with acid-catalyzed reaction showed the formation of 
linear oligomers having a hydroxyl group at one end and a carboxylic group at another end, 
with a very low proportion of cyclic structure. When Lukasiewicz and his colleagues [26] 
recently used an acid hydrolysis method, oligomeric PHA was obtained from natural mcl-
PHA. The plasticizing effect of the obtained oligomeric PHA on natural PHB was also 
studied via characterization of mechanical and thermal properties of the blends during the 
course of aging at varying ambient conditions. The oligomeric PHA obtained in this study 
was further confirmed as a suitable biodegradable and biocompatible plasticizer for natural 
PHB, where plasticizing of PHB with oligomeric PHA resulted in a softer and more flexible 
PHB biomaterial [26]. 
4.2.15 Functionalization of PHA to Oligomers Containing Hydroxyl End Groups 
Degradation of PHA via a reduction reaction with lithium borohydride leads to 
oligo(hydroxyalkanoate) diols (see Figure 4.4): 
The structural characterization of the oligomers conducted using NMR and ESI-MS
n 
analyses 
confirmed that oligomers were terminated by two hydroxyl end groups. The reduction of the 
PHA occurred in a statistical way, regardless of the chemical structure of the comonomer 
units or of the microstructure of the polyester chain [71, 72]. This method can be used to 
synthesize various PHA oligodiols that were useful in the further synthesis of tailor-made 
biodegradable materials [73, 74]. 
4.2.17 6 Bioactive Oligomers of PHA 
In a transesterification reaction, an alcohol molecule and an ester molecule react in the 
presence of acid; basically, one ester is transformed into another ester. This process leads to 
the synthesis of oligomers with either carboxyl or hydroxyl functionalities. Using this 
transesterification reaction, Kwiecień et al. [75] were able to develop two methods for the 
preparation of pesticide-oligomer conjugates. In the first method (one-pot), an MCPA-oligo 
(3HB-co-4HB) conjugate was synthesized using a transesterification reaction of poly(3-
hydroxybutyrate-co-4-hydroxybutyrate) and P(3HB-co-4HB) biopolyester with (4-chloro-2-
methylphenoxy) acetic acid (MCPA) in the presence of 4-toluenesulfonic acid monohydrate 
(see Figure 4.5). 
Oligo (3HB)-tyrosol conjugate was synthesized using a two-step approach. In the first 
approach, cyclic oligomers were obtained via a ring-closing depolymerization reaction and 
the cyclic oligomers were reacted with 4-(2-hydroxyethyl) phenol (tyrosol) in the presence of 
lipase from Candida antarctica (see Figure 4.6). 
The synthetic route to prepare a PHB-amine conjugate containing a hydrolyzable imine bond 
was also reported. A short-chain PHB crotonate obtained by moderate-temperature 
degradation of natural polyester was converted into PHB glyoxylate via ozonolysis followed 
by reductive decomposition of peroxidic products with dimethylsulfide. Aldehyde-
functionalized PHB was obtained quantitatively without polymer backbone degradation. The 
aldehyde-functionalized PHB can be a valuable biocompatible carrier for novel drug delivery 
systems [76].  
4.2.187  Copolymers Containing PHA Building Blocks 
Low  molar mass macroinitiators derived from natural PHA, containing unsaturated and 
activated by 18-crown-6 ether carboxylic end groups, were used in anionic ring-opening 
polymerization (ROP) of racemic β-butyrolactone, and new diblock copolymers of selected 
PHA (PHB, PHBV, PHO) with atactic poly[(R,S)-3-hydroxybutyrate] (aPHB) were obtained. 
The suitability of these polymeric materials for cardiovascular engineering and as blend 
compatibilizers was demonstrated [77].  
Block copolyesters containing PHA and poly(D,L-lactide) structural units were obtained with 
a microwave-assisted process [9]. The PHA oligomers used for this purpose were obtained by 
acid-catalyzed methanolysis of corresponding native PHA. 
The amphiphilic hyaluronan (HA) grafted with poly(3-hydroxyalkanoates) (PHA) oligomers, 
were obtained by a “grafting to” strategy [28]. PHA oligomers containing carboxylic terminal 
moieties were prepared by partial hydrolysis of PHA in acetic acid/water system. Such graft 
copolymers can be physically loaded with hydrophobic drugs and may serve as drug delivery 
systems. 
Nguyen [78] had earlier suggested that PHB oligomers with carboxylic acid terminal group 
could be further subjected to modifications and graft polymerization through a readily 
available radical mechanism in acrylic backbone and PHB side chain copolymers.  
4.3 Oligomers of Synthetic Analogs of Natural PHA  
4.3.1 Monodisperse Synthetic Analogs of PHA 
Monodisperse oligomers of PHA, up to the 128 repeat units (molecular mass ca. 11 000 Da, 
as revealed by MALDI MS) were synthesized by fragment coupling (see Figure 4.7). 
With these oligomers it was possible to calibrate the standards used for molar mass 
determinations of PHB by gel-permeation chromatography (GPC). 
Using the same methodology as for the isotactic monodisperse PHB the syndiotactic, atactic, 
and block oligomers of PHB, with a given sequence of (R) and (S)-configuration of the 3HB 
units along the chain were prepared. Such non-natural PHA oligomers are important for 
studying the stereoselectivity of enzymatic PHB depolymerization [22].  
4.3.2 Functional Oligomers of PHA Analogs 
The facile synthesis of biomimetic predominantly isotactic oligo-(R)-3-hydroxybutyrate by 
region-selective anionic polymerization of (S)-ββ-butyrolactone initiated with 3-hydroxyacid 
sodium salt/crown ether complexes was described [79]. 
Such a synthetic analog of natural PHB was used for the preparation of the models of 
artificial channels in cell membranes. Das et al. [80] found that complexes of biomimetic 
OHBs with Mn 1670 and Đ 1.2 and with inorganic polyPs can be used to create serviceable 
artificial cation channels of limited divalent cation selectivity in planar bilayers. 
Piddubniak et al. [81] described the chemical synthesis and toxicity studies of well-defined 
tailor-made oligo-[R,S]-3-hydroxybutyrates (OHBs). The results indicate potential 
applicability of these oligomers as drug delivery carriers. Several OHBs with a number 
average  molar mass (Mn) ranging from 800 to 2 400 have been synthesized and tested on 
transformed hamster V79 fibroblasts and murine melanoma B16(F10) cells using the 3-[4,5-
dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT)-based drug resistance and 
clonogenic survival assays. It was shown that 96 h incubation of cells with 1–9 mg/ml of 
OHBs did not affect cell viability. Moreover, incubation of OHBs with rat hepatoma FTO-2B 
cells stably transfected with a chloramphenicol acetyltransferase (CAT) gene ligated to a 
heat-inducible hsp70i gene promoter demonstrated that OHBs did not induce a cellular stress 
response. Furthermore, they demonstrate that doxorubicin conjugated with OHB is 
effectively taken up by murine melanoma B16(F10) cells in vitro and localizes in the 
cytoplasm. These data show for the first time that tailor-made biodegradable and 
biocompatible oligomers of 3-hydroxybutyric acid can be taken into consideration as 
effective, non-toxic vectors for the delivery of drugs in a conjugated form [81].  
Elustondo et al. [82] investigated the ability of aPHB to interact with living cells and isolated 
mitochondria and the effects of these interactions on membrane ion transport using a 
fluorescein derivative of aPHB. The obtained results indicated that PHB demonstrates 
ionophoretic properties in biological membranes, and this effect is most profound in 
mitochondria due to the selective accumulation of the polymer in this organelle [82].  
The transformation method of low molar mass crotonate-terminated poly(3-
hydroxybutyrate)s (PHB), obtained by anionic ROP of β-butyrolactone [83] and controlled 
degradation of high-molar mass bacterial PHB, into mono- and di-epoxy-functionalized 
reactive poly(3-hydroxybutyrate)s is via oxidation of crotonate end groups to α-3-
methyloxirane-2-carboxylates, while carboxylate terminal groups were functionalized by 
simple alkylation with epibromohydrin was described. Combining these two methods 
resulted in telechelic structures: α-3-methyloxirane-2-carboxylate-ωω-glicydyl PHB. 
Moreover, the reactivity of 3-methyloxirane groups of a functional aPHB was confirmed in 
experiments with primary amine and primary alcohol, revealing very high yield in reaction 
with alcohol, while degradation of polymer backbone was noticed during reaction with amine 
[84]. 
4.3.3 Bioactive Oligomers of PHA Analogs 
Synthetically prepared PHA oligomers were found to be non-toxic and they may be used as 
carriers covalently bounded to suitable bioactive compounds suitable for medical, cosmetic, 
agrichemical, and functional packaging applications.  
The drug delivery systems were focused on penicillin G, acetylsalicylic acid, and ibuprofen 
[85, 86, 87]. Novel conjugates of the non-steroidal anti-inflammatory drug ibuprofen were 
synthetized by anionic ring-opening polymerization of (R,S)-β-butyrolactone initiated with 
an alkali metal salt of (S)-(ţ)-2-(4-isobutylphenyl) propionic acid (ibuprofen). Using the MTT 
cell proliferation assay, it was demonstrated that such conjugates exhibited significantly 
increased potential to inhibit proliferation of HT-29 and HCT 116 colon cancer cells when 
compared to free ibuprofen. Moreover, the conjugates of ibuprofen and OHB are less toxic as 
was shown in oral acute toxicity test in rats [87]. 
Incorporation of bioactive compounds into the β-lactones structure may lead to homo- and 
co-oligoesters with a bioactive moiety covalently linked as pendant groups along an oligomer 
backbone. This synthetic strategy was applied for preparation of the PHA synthetic analogs 
with ibuprofen pendant groups [88], pesticide moieties [32], and antioxidants used in 
cosmetics [89, 90, 91]. 
4.3.4 Copolymers Containing PHA Analogs 
A synthetic aPHB oligomer possessing hydroxyl end groups, obtained in anionic 
polymerization of (R,S)-β-butyrolactone, was applied as a precursor for preparation of a 
coordination macroinitiator to be used for ε-caprolactone polymerization. The respective 
block copolymers were prepared in this way [92].  
aPHB with a bishydroxy chain terminus was obtained through ring-opening polymerization 
of (R, S)-β-butyrolactone mediated by the activated anionic initiator 2,2-
bis(hydroxymethyl)butyric acid (BHBA) tetrabutylammonium salt. Then, the polyester was 
modified to obtain a macroinitiator bifunctional species applicable in an ATRP process. Next, 
in an ATRP of methacrylic PEG macromonomer a water-soluble brush copolymer was 
synthesized [93].  
Block copolymers of (R, S)-β-butyrolactone with pivalolactone (PVL) are prepared in order 
to define the effect of crystalline domains provided by poly(pivalolactone) on the 
biodegradability of atactic poly(β-butyrolactone), aPHB. The aPHB was synthesized from 
racemic β-butyrolactone, in the presence of a potassium alkoxide/18-crown-6 complex, and 
such a living polymer was applied for polymerization of PVL, yielding block copolymers, 
aPHB-b-PPVL, of tailored molecular weight and composition. While plain aPHB does not 
biodegrade, the biodegradation rate of aPHB-b-PPVL copolymers increases along with the 
increase of crystalline PPVL domains [94].  
Graft copolymers were synthesized via an anionic grafting reaction of β-butyrolactone on 
poly(methyl methacrylate) (PMMA). Partially saponified PMMA bearing carboxylate anions 
complexed by 18-crown-6 potassium counterion acts as a macroinitiator of β-butyrolactone 
polymerization. As a result, graft polymers of PMMA with grafted poly(butyrolactone) side 
chains are produced in high yield over a wide graft composition range [95]. aPHB graft 
copolymers were also prepared via a macromonomer method, i.e., grafting through 
copolymerization [96]. Poly[(R,S)-3-hydroxybutyrate] telechelics were used for the synthesis 
of poly(methyl methacrylate)-b-poly(3-hydroxybutyrate) block copolymers [97] 
Branched, aliphatic polyurethanes (PURs) were synthesized and compared to linear analogs. 
The influence of polycaprolactonetriol and synthetic aPHB oligomers in soft segments on 
structure, thermal, and sorptive properties of PURs was determined. It was found that 
increasing the aPHB amount in the structure of branched PURs reduced a tendency of 
urethane groups to hydrogen bonding. Thus, by controlling the number of branches and the 
amount of a-PHB in soft segments, thermal and absorptive properties of aliphatic PURs could 
be controlled [98]. 
4.4 Conclusions and Outlook 
Polyhydroxyalkanoates (PHA) are a group of polyesters with excellent biodegradable and 
biocompatible properties. Additionally, their degradation products after hydrolysis are non-
toxic, therefore making this biopolymer an attractive biomaterial for various end use 
applications. However, due to several undesirable physical properties of storage PHA (e.g., 
poor mechanical properties, poor solubility) and limited functionalities, the application of 
PHA in the other areas of importance is still limited. In recent years, significant efforts have 
been made to investigate a relationship between structure, properties, and function of 
advanced biodegradable polymeric materials in order to fulfill requirements for their specific 
novel applications in the future.  
One way to increase the mechanical properties of PHA and expand their potential 
applications is to use PHA oligomers containing reactive functional end groups which could 
be used as building blocks for the preparation of new biopolymers with enhanced properties 
and high-value applications. PHA oligomers are low molecular weight PHA with a limited 
number of 3-hydroxyacids repeated units (max. 200 residual units). They are present in 
numerous intracellular fluids of all types of cells and in some cases, complexed to other 
cellular macromolecules including inorganic polyPs. They can also be synthesized either 
naturally in prokaryotic and eukaryotic cells or via several chemical modifications such as 
basic hydrolysis or transesterification. The chemical modification of storage PHA yields 
synthetic oligomers with the additional functional end groups, depending on the tailored 
functionality. These chemical modifications, such as controlled moderate-temperature 
degradation, thermal degradation, and thermo-oxidative degradation of PHB often leads to 
the synthesis of oligomers with unsaturated, carboxylic, or hydroxyl end groups.  
The PHA oligomers derived either from natural aliphatic polyesters or their synthetic analogs 
could be used as carriers covalently bound to bioactive compounds. Polymeric controlled-
release delivery systems of bioactive compounds can provide novel opportunities suitable for 
various applications in medicine, cosmetic industry, food packaging, or agri-chemistry.  
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